25 XP   0   0   10

Nantong Jinghua Pharmaceutical Co Ltd
Buy, Hold or Sell?

Let's analyse Nantong Jinghua Pharmaceutical Co Ltd together

PenkeI guess you are interested in Nantong Jinghua Pharmaceutical Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Nantong Jinghua Pharmaceutical Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Nantong Jinghua Pharmaceutical Co Ltd

I send you an email if I find something interesting about Nantong Jinghua Pharmaceutical Co Ltd.

Quick analysis of Nantong Jinghua Pharmaceutical Co Ltd (30 sec.)










What can you expect buying and holding a share of Nantong Jinghua Pharmaceutical Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.04
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥3.22
Expected worth in 1 year
¥3.81
How sure are you?
90.0%

+ What do you gain per year?

Total Gains per Share
¥0.86
Return On Investment
11.3%

For what price can you sell your share?

Current Price per Share
¥7.61
Expected price per share
¥5.88 - ¥8.5
How sure are you?
50%

1. Valuation of Nantong Jinghua Pharmaceutical Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥7.61

Intrinsic Value Per Share

¥5.27 - ¥9.68

Total Value Per Share

¥8.49 - ¥12.90

2. Growth of Nantong Jinghua Pharmaceutical Co Ltd (5 min.)




Is Nantong Jinghua Pharmaceutical Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$362.3m$354.8m$7.4m2.1%

How much money is Nantong Jinghua Pharmaceutical Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$29.3m$22.1m$7.1m24.3%
Net Profit Margin13.5%11.8%--

How much money comes from the company's main activities?

3. Financial Health of Nantong Jinghua Pharmaceutical Co Ltd (5 min.)




What can you expect buying and holding a share of Nantong Jinghua Pharmaceutical Co Ltd? (5 min.)

Welcome investor! Nantong Jinghua Pharmaceutical Co Ltd's management wants to use your money to grow the business. In return you get a share of Nantong Jinghua Pharmaceutical Co Ltd.

What can you expect buying and holding a share of Nantong Jinghua Pharmaceutical Co Ltd?

First you should know what it really means to hold a share of Nantong Jinghua Pharmaceutical Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Nantong Jinghua Pharmaceutical Co Ltd is ¥7.61. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Nantong Jinghua Pharmaceutical Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Nantong Jinghua Pharmaceutical Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥3.22. Based on the TTM, the Book Value Change Per Share is ¥0.15 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.10 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.07 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Nantong Jinghua Pharmaceutical Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.040.5%0.040.5%0.030.3%0.010.1%0.010.2%
Usd Book Value Change Per Share0.020.3%0.020.3%0.010.2%0.000.0%0.030.4%
Usd Dividend Per Share0.010.1%0.010.1%0.010.1%0.010.1%0.010.1%
Usd Total Gains Per Share0.030.4%0.030.4%0.020.3%0.010.1%0.040.5%
Usd Price Per Share1.67-1.67-1.56-1.06-1.93-
Price to Earnings Ratio46.34-46.34-58.66-30.65-144.30-
Price-to-Total Gains Ratio56.39-56.39-74.04-34.81-65.20-
Price to Book Ratio3.75-3.75-3.67-2.52-6.19-
Price-to-Total Gains Ratio56.39-56.39-74.04-34.81-65.20-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.050941
Number of shares951
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.01
Usd Book Value Change Per Share0.020.00
Usd Total Gains Per Share0.030.01
Gains per Quarter (951 shares)28.149.42
Gains per Year (951 shares)112.5437.67
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1357810330828
270155216601566
31052333299023104
413931144212031142
517438955515039180
620946666818046218
724454478121054256
827962289424062294
9314699100727069332
10348777112030077370

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%4.01.00.080.0%9.01.00.090.0%16.01.00.094.1%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%4.01.00.080.0%9.01.00.090.0%16.01.00.094.1%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%17.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%4.01.00.080.0%9.01.00.090.0%16.01.00.094.1%

Fundamentals of Nantong Jinghua Pharmaceutical Co Ltd

About Nantong Jinghua Pharmaceutical Co Ltd

Jinghua Pharmaceutical Group Co., Ltd. engages in the research and development, manufacture, and sale of APIs and pharmaceutical intermediates in China. Its primary products include Phenylbutazone, Primidone, Phenobarbital, Fluorouracil, Propylthiouracil, Piroxicam, and Flucytosine APIs. The company was formerly known as Nantong Jinghua Pharmaceutical Co., Ltd. The company was founded in 1957 and is based in Nantong, China.

Fundamental data was last updated by Penke on 2024-04-14 15:26:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is fair priced.

1.1. Profitability of Nantong Jinghua Pharmaceutical Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Nantong Jinghua Pharmaceutical Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Nantong Jinghua Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 13.5% means that ¥0.13 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Nantong Jinghua Pharmaceutical Co Ltd:

  • The MRQ is 13.5%. The company is making a huge profit. +2
  • The TTM is 13.5%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ13.5%TTM13.5%0.0%
TTM13.5%YOY11.8%+1.7%
TTM13.5%5Y3.4%+10.1%
5Y3.4%10Y7.3%-3.9%
1.1.2. Return on Assets

Shows how efficient Nantong Jinghua Pharmaceutical Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Nantong Jinghua Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 7.0% Return on Assets means that Nantong Jinghua Pharmaceutical Co Ltd generated ¥0.07 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Nantong Jinghua Pharmaceutical Co Ltd:

  • The MRQ is 7.0%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 7.0%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ7.0%TTM7.0%0.0%
TTM7.0%YOY5.0%+2.0%
TTM7.0%5Y1.8%+5.2%
5Y1.8%10Y2.9%-1.2%
1.1.3. Return on Equity

Shows how efficient Nantong Jinghua Pharmaceutical Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Nantong Jinghua Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 8.8% Return on Equity means Nantong Jinghua Pharmaceutical Co Ltd generated ¥0.09 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Nantong Jinghua Pharmaceutical Co Ltd:

  • The MRQ is 8.8%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 8.8%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ8.8%TTM8.8%0.0%
TTM8.8%YOY7.2%+1.7%
TTM8.8%5Y2.0%+6.8%
5Y2.0%10Y3.7%-1.7%

1.2. Operating Efficiency of Nantong Jinghua Pharmaceutical Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Nantong Jinghua Pharmaceutical Co Ltd is operating .

  • Measures how much profit Nantong Jinghua Pharmaceutical Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Nantong Jinghua Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 15.0% means the company generated ¥0.15  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Nantong Jinghua Pharmaceutical Co Ltd:

  • The MRQ is 15.0%. The company is operating less efficient.
  • The TTM is 15.0%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ15.0%TTM15.0%0.0%
TTM15.0%YOY11.5%+3.4%
TTM15.0%5Y10.8%+4.2%
5Y10.8%10Y11.7%-0.9%
1.2.2. Operating Ratio

Measures how efficient Nantong Jinghua Pharmaceutical Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.38 means that the operating costs are ¥1.38 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Nantong Jinghua Pharmaceutical Co Ltd:

  • The MRQ is 1.383. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.383. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.383TTM1.3830.000
TTM1.383YOY1.393-0.010
TTM1.3835Y1.362+0.021
5Y1.36210Y1.213+0.149

1.3. Liquidity of Nantong Jinghua Pharmaceutical Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Nantong Jinghua Pharmaceutical Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 4.38 means the company has ¥4.38 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Nantong Jinghua Pharmaceutical Co Ltd:

  • The MRQ is 4.381. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.381. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.381TTM4.3810.000
TTM4.381YOY2.644+1.737
TTM4.3815Y2.824+1.557
5Y2.82410Y2.586+0.238
1.3.2. Quick Ratio

Measures if Nantong Jinghua Pharmaceutical Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Nantong Jinghua Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.87 means the company can pay off ¥0.87 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Nantong Jinghua Pharmaceutical Co Ltd:

  • The MRQ is 0.872. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.872. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.872TTM0.8720.000
TTM0.872YOY0.972-0.100
TTM0.8725Y0.862+0.010
5Y0.86210Y0.866-0.005

1.4. Solvency of Nantong Jinghua Pharmaceutical Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Nantong Jinghua Pharmaceutical Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Nantong Jinghua Pharmaceutical Co Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.14 means that Nantong Jinghua Pharmaceutical Co Ltd assets are financed with 13.7% credit (debt) and the remaining percentage (100% - 13.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Nantong Jinghua Pharmaceutical Co Ltd:

  • The MRQ is 0.137. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.137. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.137TTM0.1370.000
TTM0.137YOY0.197-0.059
TTM0.1375Y0.205-0.067
5Y0.20510Y0.190+0.015
1.4.2. Debt to Equity Ratio

Measures if Nantong Jinghua Pharmaceutical Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Nantong Jinghua Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 17.4% means that company has ¥0.17 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Nantong Jinghua Pharmaceutical Co Ltd:

  • The MRQ is 0.174. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.174. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.174TTM0.1740.000
TTM0.174YOY0.281-0.107
TTM0.1745Y0.302-0.128
5Y0.30210Y0.276+0.026

2. Market Valuation of Nantong Jinghua Pharmaceutical Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Nantong Jinghua Pharmaceutical Co Ltd generates.

  • Above 15 is considered overpriced but always compare Nantong Jinghua Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 46.34 means the investor is paying ¥46.34 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Nantong Jinghua Pharmaceutical Co Ltd:

  • The EOD is 29.194. Based on the earnings, the company is overpriced. -1
  • The MRQ is 46.342. Based on the earnings, the company is overpriced. -1
  • The TTM is 46.342. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD29.194MRQ46.342-17.148
MRQ46.342TTM46.3420.000
TTM46.342YOY58.661-12.319
TTM46.3425Y30.647+15.695
5Y30.64710Y144.298-113.651
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Nantong Jinghua Pharmaceutical Co Ltd:

  • The EOD is 20.875. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 33.137. Based on how much money comes from the company's main activities, the company is fair priced.
  • The TTM is 33.137. Based on how much money comes from the company's main activities, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD20.875MRQ33.137-12.262
MRQ33.137TTM33.1370.000
TTM33.137YOY41.893-8.756
TTM33.1375Y31.374+1.763
5Y31.37410Y13.931+17.443
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Nantong Jinghua Pharmaceutical Co Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Nantong Jinghua Pharmaceutical Co Ltd:

  • The EOD is 2.361. Based on the equity, the company is underpriced. +1
  • The MRQ is 3.749. Based on the equity, the company is fair priced.
  • The TTM is 3.749. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD2.361MRQ3.749-1.387
MRQ3.749TTM3.7490.000
TTM3.749YOY3.669+0.080
TTM3.7495Y2.517+1.232
5Y2.51710Y6.193-3.676
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Nantong Jinghua Pharmaceutical Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.1480.1480%0.099+49%0.015+907%0.234-37%
Book Value Per Share--3.2233.2230%3.075+5%3.013+7%2.658+21%
Current Ratio--4.3814.3810%2.644+66%2.824+55%2.586+69%
Debt To Asset Ratio--0.1370.1370%0.197-30%0.205-33%0.190-28%
Debt To Equity Ratio--0.1740.1740%0.281-38%0.302-42%0.276-37%
Dividend Per Share--0.0660.0660%0.053+25%0.057+16%0.048+38%
Eps--0.2610.2610%0.192+36%0.078+235%0.099+164%
Free Cash Flow Per Share--0.3650.3650%0.269+35%0.166+120%0.066+455%
Free Cash Flow To Equity Per Share--0.1410.1410%0.058+141%0.086+64%0.073+92%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--9.682--------
Intrinsic Value_10Y_min--5.269--------
Intrinsic Value_1Y_max--0.441--------
Intrinsic Value_1Y_min--0.260--------
Intrinsic Value_3Y_max--1.729--------
Intrinsic Value_3Y_min--1.017--------
Intrinsic Value_5Y_max--3.503--------
Intrinsic Value_5Y_min--2.029--------
Market Cap6195917349.120-59%9835306383.3609835306383.3600%9426970938.720+4%6378014522.644+54%11471482066.968-14%
Net Profit Margin--0.1350.1350%0.118+14%0.034+298%0.073+85%
Operating Margin--0.1500.1500%0.115+30%0.108+39%0.117+28%
Operating Ratio--1.3831.3830%1.393-1%1.362+2%1.213+14%
Pb Ratio2.361-59%3.7493.7490%3.669+2%2.517+49%6.193-39%
Pe Ratio29.194-59%46.34246.3420%58.661-21%30.647+51%144.298-68%
Price Per Share7.610-59%12.08012.0800%11.280+7%7.694+57%13.995-14%
Price To Free Cash Flow Ratio20.875-59%33.13733.1370%41.893-21%31.374+6%13.931+138%
Price To Total Gains Ratio35.522-59%56.38856.3880%74.042-24%34.806+62%65.201-14%
Quick Ratio--0.8720.8720%0.972-10%0.862+1%0.866+1%
Return On Assets--0.0700.0700%0.050+39%0.018+292%0.029+138%
Return On Equity--0.0880.0880%0.072+23%0.020+338%0.037+136%
Total Gains Per Share--0.2140.2140%0.152+41%0.072+199%0.283-24%
Usd Book Value--362338979.787362338979.7870%354855744.883+2%345862751.686+5%303573828.101+19%
Usd Book Value Change Per Share--0.0200.0200%0.014+49%0.002+907%0.032-37%
Usd Book Value Per Share--0.4450.4450%0.425+5%0.416+7%0.367+21%
Usd Dividend Per Share--0.0090.0090%0.007+25%0.008+16%0.007+38%
Usd Eps--0.0360.0360%0.027+36%0.011+235%0.014+164%
Usd Free Cash Flow--40988672.66740988672.6670%31075817.417+32%18914212.988+117%4412988.131+829%
Usd Free Cash Flow Per Share--0.0500.0500%0.037+35%0.023+120%0.009+455%
Usd Free Cash Flow To Equity Per Share--0.0190.0190%0.008+141%0.012+64%0.010+92%
Usd Market Cap855656185.913-59%1358255811.5421358255811.5420%1301864686.637+4%880803805.577+54%1584211673.448-14%
Usd Price Per Share1.051-59%1.6681.6680%1.558+7%1.063+57%1.933-14%
Usd Profit--29309369.76529309369.7650%22192968.284+32%8837748.128+232%11234051.640+161%
Usd Revenue--217239560.341217239560.3410%187521572.682+16%185727277.889+17%149335193.999+45%
Usd Total Gains Per Share--0.0300.0300%0.021+41%0.010+199%0.039-24%
 EOD+4 -4MRQTTM+0 -0YOY+31 -45Y+30 -510Y+25 -10

3.2. Fundamental Score

Let's check the fundamental score of Nantong Jinghua Pharmaceutical Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1529.194
Price to Book Ratio (EOD)Between0-12.361
Net Profit Margin (MRQ)Greater than00.135
Operating Margin (MRQ)Greater than00.150
Quick Ratio (MRQ)Greater than10.872
Current Ratio (MRQ)Greater than14.381
Debt to Asset Ratio (MRQ)Less than10.137
Debt to Equity Ratio (MRQ)Less than10.174
Return on Equity (MRQ)Greater than0.150.088
Return on Assets (MRQ)Greater than0.050.070
Total6/10 (60.0%)

3.3. Technical Score

Let's check the technical score of Nantong Jinghua Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose7.500
Total0/1 (0.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2018-12-312019-12-312020-12-312021-12-312022-12-31
Minority Interest  412,400-114,593297,80781,427379,234-358,49020,743-20,806-63



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets3,041,678
Total Liabilities417,934
Total Stockholder Equity2,400,966
 As reported
Total Liabilities 417,934
Total Stockholder Equity+ 2,400,966
Total Assets = 3,041,678

Assets

Total Assets3,041,678
Total Current Assets1,729,043
Long-term Assets1,312,634
Total Current Assets
Cash And Cash Equivalents 933,267
Short-term Investments 124,953
Net Receivables 219,069
Inventory 307,653
Other Current Assets 918
Total Current Assets  (as reported)1,729,043
Total Current Assets  (calculated)1,585,861
+/- 143,182
Long-term Assets
Property Plant Equipment 708,416
Goodwill 167,944
Intangible Assets 65,064
Other Assets 324,243
Long-term Assets  (as reported)1,312,634
Long-term Assets  (calculated)1,265,668
+/- 46,967

Liabilities & Shareholders' Equity

Total Current Liabilities394,631
Long-term Liabilities23,303
Total Stockholder Equity2,400,966
Total Current Liabilities
Short Long Term Debt 21,026
Accounts payable 139,606
Other Current Liabilities 5,680
Total Current Liabilities  (as reported)394,631
Total Current Liabilities  (calculated)166,312
+/- 228,319
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt913
Other Liabilities 22,391
Long-term Liabilities  (as reported)23,303
Long-term Liabilities  (calculated)23,303
+/- 0
Total Stockholder Equity
Common Stock814,181
Retained Earnings 677,975
Other Stockholders Equity 2,887
Total Stockholder Equity (as reported)2,400,966
Total Stockholder Equity (calculated)1,495,043
+/- 905,923
Other
Capital Stock814,181
Common Stock Shares Outstanding 814,181
Net Invested Capital 2,421,992
Net Working Capital 1,334,412
Property Plant and Equipment Gross 708,416



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
> Total Assets 
198,187
200,108
195,949
220,370
611,414
780,529
957,711
1,070,815
1,886,557
2,506,085
2,530,495
3,241,588
3,399,702
2,941,339
3,156,027
3,198,096
3,041,678
3,041,6783,198,0963,156,0272,941,3393,399,7023,241,5882,530,4952,506,0851,886,5571,070,815957,711780,529611,414220,370195,949200,108198,187
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
1,048,495
872,819
1,256,112
1,219,578
1,102,671
1,420,651
1,595,066
1,729,043
1,729,0431,595,0661,420,6511,102,6711,219,5781,256,112872,8191,048,495000000000
       Cash And Cash Equivalents 
9,890
22,880
24,726
57,087
401,797
365,959
201,947
135,763
866,292
484,832
386,167
387,855
211,462
300,136
581,319
651,593
933,267
933,267651,593581,319300,136211,462387,855386,167484,832866,292135,763201,947365,959401,79757,08724,72622,8809,890
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
36,265
114,744
213,358
124,953
124,953213,358114,74436,2650000000000000
       Net Receivables 
30,231
30,225
28,518
31,475
32,113
105,953
151,225
200,900
147,046
317,952
172,191
347,731
528,663
381,202
235,441
373,059
219,069
219,069373,059235,441381,202528,663347,731172,191317,952147,046200,900151,225105,95332,11331,47528,51830,22530,231
       Other Current Assets 
1,291
425
2,283
2,159
28,440
47,390
4,599
31,942
19,100
23,225
21,757
104,335
34,010
38,730
26,997
33,933
918
91833,93326,99738,73034,010104,33521,75723,22519,10031,9424,59947,39028,4402,1592,2834251,291
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
1,657,676
1,985,476
2,180,123
1,838,667
1,735,377
1,603,031
1,312,634
1,312,6341,603,0311,735,3771,838,6672,180,1231,985,4761,657,6760000000000
       Property Plant Equipment 
104,572
95,947
87,704
93,747
95,236
166,593
358,856
500,795
479,527
551,864
713,139
1,042,808
1,222,418
1,273,204
1,210,569
1,169,051
708,416
708,4161,169,0511,210,5691,273,2041,222,4181,042,808713,139551,864479,527500,795358,856166,59395,23693,74787,70495,947104,572
       Goodwill 
0
0
0
0
0
0
0
0
40,396
607,845
606,633
564,540
570,103
176,001
167,944
167,944
167,944
167,944167,944167,944176,001570,103564,540606,633607,84540,39600000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
146,040
127,693
115,974
117,273
0
0
0
0
0000117,273115,974127,693146,040000000000
       Intangible Assets 
10,497
10,336
10,557
536
321
634
91,428
0
162,152
138,182
177,910
204,373
229,998
182,759
153,455
147,172
65,064
65,064147,172153,455182,759229,998204,373177,910138,182162,152091,42863432153610,55710,33610,497
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
20,518
42,924
5,110
28,583
30,112
24,953
1,617
1,61724,95330,11228,5835,11042,92420,5180000000000
> Total Liabilities 
128,184
108,252
77,293
83,260
66,964
144,231
242,841
328,986
351,959
272,269
227,872
594,465
705,269
793,625
669,289
628,540
417,934
417,934628,540669,289793,625705,269594,465227,872272,269351,959328,986242,841144,23166,96483,26077,293108,252128,184
   > Total Current Liabilities 
116,053
103,190
73,198
79,617
58,409
118,321
171,900
257,755
273,761
261,026
217,509
338,475
504,587
554,178
528,484
603,237
394,631
394,631603,237528,484554,178504,587338,475217,509261,026273,761257,755171,900118,32158,40979,61773,198103,190116,053
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
20,000
50,000
174,000
0
0
0
0
0000174,00050,00020,0000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
20,000
50,000
174,000
210,500
76,568
68,782
21,026
21,02668,78276,568210,500174,00050,00020,0000000000000
       Accounts payable 
24,206
25,840
26,227
28,277
29,632
78,541
100,415
127,151
76,563
69,259
63,518
162,567
121,523
109,835
180,609
213,059
139,606
139,606213,059180,609109,835121,523162,56763,51869,25976,563127,151100,41578,54129,63228,27726,22725,84024,206
       Other Current Liabilities 
31,147
37,350
16,971
26,340
28,777
39,780
53,685
55,604
77,260
20,883
58,079
48,752
60,224
59,920
182,015
95,610
5,680
5,68095,610182,01559,92060,22448,75258,07920,88377,26055,60453,68539,78028,77726,34016,97137,35031,147
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
10,363
255,990
200,682
239,447
140,805
25,303
23,303
23,30325,303140,805239,447200,682255,99010,3630000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
-20,000
-50,000
-174,000
0
4,976
3,881
913
9133,8814,9760-174,000-50,000-20,0000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
738
310
253
202
178
147
122
1221471782022533107380000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
8,100
28,670
60,015
73,653
40,639
41,280
37,923
0
037,92341,28040,63973,65360,01528,6708,100000000000
> Total Stockholder Equity
70,003
91,847
118,646
137,100
544,440
585,145
624,447
669,856
1,383,292
2,036,099
2,149,084
2,281,387
2,282,033
1,849,907
2,107,505
2,235,839
2,400,966
2,400,9662,235,8392,107,5051,849,9072,282,0332,281,3872,149,0842,036,0991,383,292669,856624,447585,145544,440137,100118,64691,84770,003
   Common Stock
60,000
60,000
60,000
60,000
80,000
100,000
200,000
200,000
260,000
280,197
420,295
840,590
835,724
835,724
835,724
835,724
814,181
814,181835,724835,724835,724835,724840,590420,295280,197260,000200,000200,000100,00080,00060,00060,00060,00060,000
   Retained Earnings 
5,596
7,232
30,786
45,313
75,697
111,016
146,688
167,623
221,051
273,132
410,143
522,418
710,054
276,278
387,272
514,593
677,975
677,975514,593387,272276,278710,054522,418410,143273,132221,051167,623146,688111,01675,69745,31330,7867,2325,596
   Capital Surplus 00000000000000000
   Treasury Stock00000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
3,965
-19,827
6,059
193
1,661
133
1,142
2,887
2,8871,1421331,6611936,059-19,8273,965000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue1,517,690
Cost of Revenue-801,909
Gross Profit715,781715,781
 
Operating Income (+$)
Gross Profit715,781
Operating Expense-1,278,202
Operating Income239,489-562,420
 
Operating Expense (+$)
Research Development83,967
Selling General Administrative259,649
Selling And Marketing Expenses-
Operating Expense1,278,202343,616
 
Net Interest Income (+$)
Interest Income8,148
Interest Expense-3,102
Other Finance Cost-8,582
Net Interest Income13,627
 
Pretax Income (+$)
Operating Income239,489
Net Interest Income13,627
Other Non-Operating Income Expenses-
Income Before Tax (EBT)281,356239,489
EBIT - interestExpense = -3,102
238,706
241,808
Interest Expense3,102
Earnings Before Interest and Taxes (EBIT)-284,458
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax281,356
Tax Provision-38,307
Net Income From Continuing Ops243,049243,049
Net Income238,706
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--13,627
 

Technical Analysis of Nantong Jinghua Pharmaceutical Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Nantong Jinghua Pharmaceutical Co Ltd. The general trend of Nantong Jinghua Pharmaceutical Co Ltd is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Nantong Jinghua Pharmaceutical Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Nantong Jinghua Pharmaceutical Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 7.42 < 8.11 < 8.5.

The bearish price targets are: 5.88.

Tweet this
Nantong Jinghua Pharmaceutical Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Nantong Jinghua Pharmaceutical Co Ltd. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Nantong Jinghua Pharmaceutical Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Nantong Jinghua Pharmaceutical Co Ltd.

Nantong Jinghua Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartNantong Jinghua Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Nantong Jinghua Pharmaceutical Co Ltd. The current adx is .

Nantong Jinghua Pharmaceutical Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Nantong Jinghua Pharmaceutical Co Ltd.

Nantong Jinghua Pharmaceutical Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Nantong Jinghua Pharmaceutical Co Ltd.

Nantong Jinghua Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) ChartNantong Jinghua Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Nantong Jinghua Pharmaceutical Co Ltd.

Nantong Jinghua Pharmaceutical Co Ltd Daily Stochastic Oscillator ChartNantong Jinghua Pharmaceutical Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Nantong Jinghua Pharmaceutical Co Ltd.

Nantong Jinghua Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) ChartNantong Jinghua Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Nantong Jinghua Pharmaceutical Co Ltd.

Nantong Jinghua Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) ChartNantong Jinghua Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Nantong Jinghua Pharmaceutical Co Ltd.

Nantong Jinghua Pharmaceutical Co Ltd Daily Williams %R ChartNantong Jinghua Pharmaceutical Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Nantong Jinghua Pharmaceutical Co Ltd.

Nantong Jinghua Pharmaceutical Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Nantong Jinghua Pharmaceutical Co Ltd.

Nantong Jinghua Pharmaceutical Co Ltd Daily Average True Range (ATR) ChartNantong Jinghua Pharmaceutical Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Nantong Jinghua Pharmaceutical Co Ltd.

Nantong Jinghua Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) ChartNantong Jinghua Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Nantong Jinghua Pharmaceutical Co Ltd.

Nantong Jinghua Pharmaceutical Co Ltd Daily Money Flow Index (MFI) ChartNantong Jinghua Pharmaceutical Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Nantong Jinghua Pharmaceutical Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-23STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-24ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-29CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-30CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-01CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-05WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-06CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-18CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-25STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-26STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-03DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-24MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-31BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-02-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-20CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-23WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-04MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-19RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-26CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-03CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Nantong Jinghua Pharmaceutical Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Nantong Jinghua Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose7.500
Total0/1 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Nantong Jinghua Pharmaceutical Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Nantong Jinghua Pharmaceutical Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Nantong Jinghua Pharmaceutical Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Nantong Jinghua Pharmaceutical Co Ltd

I send you an email if I find something interesting about Nantong Jinghua Pharmaceutical Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Nantong Jinghua Pharmaceutical Co Ltd.

Receive notifications about Nantong Jinghua Pharmaceutical Co Ltd in your mailbox!